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The scrine protease a-thrombin (thrombin) potently stimulates G-protein-coupled signaling pathways and DNA synthesis in CCL39 hamster lung 
Abroblasts. To clone a thrombin receptor cDNA, selcctivc amplification of mRNA sequences displaying homology to the transmembrane domains 
of G-protein-coupled receptor genes was performed by polymerasc chain reaction. Using rcverae transcribed poly(A)+ RNA from CCL39 cells 
and degenerate primers corresponding to conserved regions of several phospholipase C-coupled receptors, three novel putative receptor sequences 
were identified. One corresponds to an mRNA transcript of 3.4 kb in CCL39 cells and a relatively abundant cDNA. Microinjection of RNA tran- 
scribed in vitro from this cDNA in Xenopus oocytcs leads to the expression of a functional thrombin receptor. The hamster thrornbin receptor 
consists of 427 amino acid residues with 8 hydrophobic domains, in&ding one at the extreme N-terminus that is likely to represent a signal peptide. 
A thrombin consensus cleavage site is present in the N-terminal extracellular region of the receptor squcnce followed by a negatively charged 
cluster of residues present in a number of proteins that interact with the anion-binding exositc of thrombin. 
u-Thrombin receptor; G-protein; Phospholipase C; Polymerase chain reaction; Oocyte expression; Hamster ftbroblast 
1. INTRODUCTION 
Procoagulant cx-thrombin (thrombin) plays a central 
role in hemostasis by converting fibrinogen to fibrin 
monomers that polymerize and form the matrix of 
blood clots. Thrombin is also involved in the process of 
wound healing and in pathological disorders involving 
the vascular or perivascular wall such as atherosclerosis 
by virtue of its effects on various cell types including 
platelets, endothelial cells, vascular smooth muscle, and 
fibroblasts (for review see [l]). Extensive studies by 
several aboratories have shown that thrombin elicits 
cellular responses via guanine nucleotide-binding pro- 
teins (G-proteins). In a line of Chinese hamster lung 
fibroblasts, CCL39 cells, G-proteins mediate thrombin 
activation of phosphoinositide-specific phospholipase 
C (PLC) [2,3] and inhibition of adenylate cyclase [4]. In 
addition to these rapid effects, thrombin potently 
stimulates DNA synthesis in CCL39 cells in a pertussis 
toxin-sensitive manner [5], indicating that one or more 
G-proteins participate in the stimulation of cell cycle re- 
entry. 
Isolation and characterization of surface receptors 
for thrombin that interact with intracellular effecters 
has been a difficult task. Whereas thrombin appears to 
Corrcs/>o&/lce oddrcss: E. Van ObberghcnSchilling, Ccntrc dc tiighly purified thrombin (3209 NIH U/mg) was a generous gift of 
Hiochimic, C.N,R.S., Part Valrose, 06043 Nice Ccdcx, Prance Fax: Dr J.W. Pcruon It (New York State Department of Health, Albany, 
(33) (93) 52 99 17. NY, USA). Scrotonin was from Sigma (St. Loci , MO, USA). 
behave similarly to other agonists that activate .G- 
protein-coupled receptors, in terms of the dose depend- 
ency and ligand-induced esensitization of its effects 
[6-g], there is considerable circumstantial evidence that 
proteolysis plays a role in the activation process. An ac- 
tive catalytic site on the enzyme is required for stimula- 
tion of biological responses, in CCL39 cells [9], as well 
as in platelets [lo]. Furthermore, enzymes with similar 
specificity for arginyl residues uch as trypsin, are able 
to mimic thrombin’s action in platelets 161, CCL39 cells 
(unpublished observations) and human erythroleuke- 
mic cells (HEL) [8]. As a first step in isolating a cDNA 
clone encoding the receptor, we have previously demon- 
strated functional expression of thrombin receptors in 
Xenopus oocytes following microinjection of CCL39 
cell mRNA [ll]. In the present study, we have 
employed the technique of PCR to selectively amplify 
members of the G-protein-coupled receptor family ex- 
pressed by CCL39 cells [ 121. A cDNA clone has been 
isolated with structural features and functional proper- 
ties of a thrombin receptor coupled to PLC when ex- 
pressed in Xenopus oocytes. 
2. MATERIALS AND METHODS 
2.1. Malcrials 
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2.2. RNA isola!ion 
RNA was isolated by rapid homogenization of cultured cells or 
tissues in a solution containing 3 M LiCl/6 M urea, 10 mM sodium 
acetate (pN 5.2) and 0.05% SDS, followed by precipitation overnight 
at 4°C. Poly(A)+ RNA was selected by oligo d(T)-cellulose affinity 
chromatography. CCL39 cell poly(A)+ RNA 23 kb, enriched in 
thrombin receptor mRNA. was obtained by sucrose density gradient 
centrifugation (IO-30%) for 16 h at 4’C as described [l I]. 
2.3. Norrlrern arralysis 
For Northern blot analyses, the indicated amounts of RNA were 
eletrophorescd on I % agarose gels containing 0.66 M formaldehyde 
and transferred to Hybond-N hybridization membrane (Amersham, 
France). Blots were hybridized as described by Church [ 131 with probes 
labeled by random priming with “P. 
2.4. PCR and subcloning 
Enriched CCL39 cell poly(A)+ RNA (1 ag) was reverse transcribed 
by random hexanucleotide priming. A 2 aI aliquot of single strand 
cDNA was directly amplified in 50 ~1 containing 10 mM Tris (pH 8.3). 
10 mM KCI, 1.6 mM MgCl2, 1 mM DTT, 200 mM dNTP’s, 300 ng 
each of the 3’ and 5 ’ primers and 2.5 IJ of Taq polymerase (AmpliTaq 
DNA polymerase, Perkin-Elmer-Cetus, Norwalk, CT, USA). PCR 
amplifications were performed as follows: denaturation at 93”C/3 
min, followed by 5 cycles of 45OC/2 min, 72”C/4min, 93OCI1.5 min. 
then 25 cycles of 55”C/t min, 72”C/4 min, 93OCI1.5 min ending with 
an extension step at 72°C for 10 min. One ~1 of this reaction product 
was re-amplified using the same program. Primer pairs used for PCR 
were designed by alignment of nucleotide sequences in transmem- 
brane domains 11, Ill, VI and VII of the following PLC-coupled 
receptors: hamster n-l adrencrgic 1141, rat muscarinic ml and m3 
1151, rat 5-HTlc 116) hamster 5-HT2 1171, bovine substance K 1181 
receptors, and the MAS oncogene [l9]. 
Primers that successfully amplified the thrombin receptor sequence 
are located in transmembrane domains II and III (see legend to Fig. 
2 for exact positions); their sequences are: 
(5’ primer) ATGTCGACTTC(C/A)T(G/C)(A/G)T(G/C)AICCTG- 
GCCA(T/G)(C/T)GCTGA including a SalI restriction site at the 5’ 
end, and 
(3’ primer) GAAAGCTTCGTACC(T/G)GTC(C/A)AI(A/G)(G/C)- 
(A/T)(A/G)ATG including a Hind111 restriction site at the 5’ end. 
After phenol extraction and ethanol precipitation, the amplified 
DNA was cut with Safl and Hindlll and electrophoresed on a 1% low 
melting point agarose gel. A broad band of about 200 bp was 
purified, ligated into the Ml3 vector pTGl30 and used to transform 
E. co/i NM522 using standard protocols. Of 7 randomly picked white 
plaques, 5 were sequenced and all contained the same insert sequence 
which was 186 bp long and showed homology to the G-protein- 
coupled superfamily between transmembrane domain II and III. This 
insert, E2-03, was labeled with “P by random priming and used for 
probing Northern blots and a cDNA library. 
2.5. cDNA isolation and characrerization 
cDNA was synthesized using enriched CCL39 cell poly(A)’ RNA 
primed with oligo(dT), and inserted with fZcoR1 linkers in the 
bacteriophage expression vector XZAP (Stratagcne, La Jolla, CA, 
USA). The “P-labeled insert, E2-03, was used as a probe to screen IO6 
recombinants under stringent hybridization conditions. Of 96 positive 
clones obtained, 5 were chosen for phagcmid excision, and sequenced 
using the Sequenase system (United States Biochemical Corporation, 
Cleveland, OH, USA). One clone with an insert of 2.8 kb containing 
a 1.28 kb open rending frame (pTG4403) was used for furthcl 
analysis. 
2.6, In vllro RNA synrlresis and ex,wessiotr /tt Xcnopus oocyrp~ 
Phagcmids pTG4403 and pTG4402 corresponding to the thronrbin 
rcccptor, and OS control pCHSR coding for the hamster 5+1T2 rcccp. 
tor 1171, were linearircd and usctl for in vitro transcriptlou with RNA 
polynicrasc (f7 or T3) and the Stratugcnc RNA TranscrIptIon Quffcr 
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Kit. Transcription was carried out as described by the manufacturer 
for non-radioactive transcripts except that capping of the transcript 
was performed in the presence of 200 pM m7G(S’)ppp(S’)G (New 
England Biolabs, Beverly, MA, USA) (15 min, 37’C) prior to the 
elongation reaction. The transcription product was resuspended in 
Hz0 at the indicated concentration for microinjection in collagenase- 
treated Dumont stage V and VI Xenoprts oocytes. lsolation and 
preparation of oocytes for microinjection has previously been detail- 
ed [Ill. Thrombin or 5HT-2 receptor expression in microinjected 
oocytes was determined by measuring agonist-stimulated %a’ efflux 
in oocytes pre-loaded for 4-6 h with the isotope (Calcium-45; 50 
&i/ml, Amersham), as described [l I]. 
3. RESULTS AND DISCUSSION 
3. I. Amplification and mRNA expression of 
G-protein-coupled receptor sequences 
Initial attempts to isolate a cDNA clone for the 
thrombin receptor by expression cloning in the Xeno- 
pus oocyte system were unsuccessful. Consequently, we 
chose to selectively amplify cDNA’s encoding G- 
protein-coupled receptors by PCR, using fractionated 
CCL39 cell mRNA enriched in thrombin receptor 
message [l l] as starting material. Since thrombin has 
been shown to potently activate PLC and Ca’* mobili- 
zation in CCL39 fibroblasts, as well as in a number of 
other cell types via G-protein-mediated pathways, 
several degenerate nucleotide primer pairs were design- 
ed with homology to sequences within transmembrane 
domains II, III, VI and VII of G-protein-coupled recep- 
tors that activate PLC. Following low stringency PCR, 
amplified DNA fragments with the expected size were 
subcloned and their translated sequences were examined 
for the presence of G-protein-coupled receptor features 
(highly conserved residues and characteristic hydro- 
pathic profile). Among 90 sequences analyzed (several 
of which were identical), three corresponded to novel 
sequences for putative receptors of this family; all three 
were obtained with different primer pairs. In addition, 
sequences for the previously published hamster or-l- 
adrenergic [14J and S-HT2 receptors [17], both coupled 
to the activation of PLC, were identified. 
One of the three novel PCR-generated fragments, 
designated E2-03 (see section 2), hybridized to an abun- 
dant transcript of 3.4 kb on Northern blots of CCL39 
cell RNA (Fig. la). Probes corresponding to the other 
two novel sequences, failed to hybridize significantly to 
CCL39 cell mRNA. Poly(A)’ RNA isolated from 
human erythroleukemic (HEL) cells, a cell line that 
displays several markers indicative of megakaryocytic 
differentiation [2OJ and responsiveness to thrombin also 
hybridized to the putative thrombin receptor probe. In 
the human cells, however, the major transcript was 
slightly larger (= 3.5 kb) than that seen in hamster cells. 
In addition, less abundant smaller species were also pre- 
sent. A unique transcript of 3.4 kb was detected in a 
number of rat tissues (Fig. 1 b), among which the ex- 
pression level was highest in the lung. 
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Fig. 1. (a) A Northern blot of poly(A)+ RNA from human erythrolcukemia cells (HEL) (4 pg in lane I ; 10 fig in lane 2) and CCL39 cells (10 cg 
in lane 3) was hybridized with the 32P-labeled PCR fragment, E2-03. (b) RNA blot analysis of the putative thrombin receptor expression was per- 
formed on poly(A)+ RNA from the indicated aduIt rat tissues. and CCL39 cells. The amount of RNA deposited was 12 pg for all rat tissues, except 
5 gg for skeletal muscle, and 10 pg for CCL39 cell RNA. A ~400 bp Psll fragment of pTG4403 located in the 5 ’ end of the coding region was 
used as probe. 
3.2. Functional expression of the thrornbin receptor in 
Xencpus oocytes 
A CCL-39 cell library constructed with the same 
thrombin receptor-enriched mRNA that was used for 
PCR, was screened with the three novel PCR-generated 
probes. No positive clones were detected with the two 
probes that failed to hybridize to CCL39 mRNA, 
whereas the E2-03 probe hybridized to several clones 
(O.Olalo in the ‘enriched’ library). 
To determine whether cDNA clones isolated with 
E2-03 encode a thrombin receptor the corresponding 
RNA was synthesized in vitro and tested for functional 
expression in Xenopus oocytes. Expression of thrombin 
receptors coupled to CaZc mobilization in oocytes 
microinjected with CCL39 cell mRNA has previously 
been demonstrated using a Ca” efflux assay [l I]. This 
assay is based on the observation that activation of PLC 
by G-protein-coupled receptors leads to an increase in 
intracellular Ca’+ concentrations which results in an ef- 
flux of Ca2+ measured by *%a’* release in oocytes pre- 
loaded with the isotope. As shown in Table 1, oocytes 
microinjected with RNA transcribed from a cDNA 
clone carrying a 2.8 kbp insert (pTG4403) responded to 
thrombin. A similar increase in CaZC efflux was elicited 
by S-UT in oocytes injected with RNA coding for the 
cloned S-HT2 receptor. Under the same conditions, 
non-injected oocytes, or oocytes injected with RNA 
transcribed from a truncated thrombin receptor cDNA 
clone, pTG4402 (lacking an initiation codon) were 
refractory to stimulation by thrombin. 
3.3, Characlerization of the throrabin receptor cDlVA 
clone 
Scvcral thrombin receptor cDNA clones were 
characterized. The nucleotide and deduced amino acid 
sequence of one of these cDNAs that gave a positive 
response in the oocyte assay (pTG4403) is shown in Fig. 
2a. pTG4403 contains a 5’ untranslated region of 36 
bp, an open reading frame of 1281 bp, and a long 3 ’ un- 
translated region of 1539 bp ending in a poly(A)+ tail. 
The sequence AATACA is present 21 bases upstream 
from the polyadenylation site in pTG4403, and in at 
least 4 other indepe:;dent cDNA’s that were sequenced. 
This hexamer has been observed, albeit rarely (2%), in 
the 3’ termini of verrebrate mRNA’s and may serve as 
a functional polyadcnylation signal [21]. The open 
reading frame initiates at a ‘Kozak’ consensus sequence 
[22] and encodes a 427 amino acid protein (calculated 
M, = 47 475), in the proper reading frame with respect 
to the primers designed for PCR. Eight hydrophobic 
segments are predicted from the hydropathy plot of the 
deduced amino acid sequence (Fig. 2b). Based on 
Table 1 
Expression of thrombin receptors in Xerroprrs oocytcs 
RNA Thrombin S-HT 
pTG4403 2.12 + 0.30 (n= 19) 
Non-injected 0.72 & 0.08 (n = 16) 
pTG4402 0.95 f 0.13 (n=7) 
pCHSR 3.34 2 0.59 (n=8) 
‘“Ca” cfflux was determined on single collagcnasc-treated oocytcs 48 
h aficr microinjection with 50 nl of RNA (0.5 mg/ml) corresponding 
to: the putative thrombin rcccptor, clones pTG4403 (WC Fig. 2) and 
pTG4402 (lacking 94 bp of S ’ scqucncc as compared to pTG4403), or 
to the cloned S-HT2 receptor. Oocytcs wcrc stimulated ror 2 min with 
thrombin (10” M) or S-HT (IO” M), as indicated, Results arc 
prcscntcd as the fold-stimulation of’%‘* rclcascd during a 2 tnln in- 
cubation in the prescncc ofagonist. The data prcscntcd wcrc obtained 
in 3 Indcpcndcnt cxpcrhwm using diff’crcat nnimnl donors, 
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CCGCGQXGCCCGGCCCCGCGGGCAGCCICGGGACA ATG GGG CCG CAG CGC TIC CTG CTC GTC GCC GCt GGC CTC AGC’CTG TGC CGT 87 
N G P 0 R L L L VA A G L 5 L C G 17 
CCC TIC CTG TCI ‘XC CGT GK CCC GTG CGC -G CCA GM TCT GAG ATG ACA GAT GCC ACT tTG AM CCC CGC ‘KA TtT TTT CTT 171 
PLLSSPVPVRQPESEHTDATVNPRSFFL 45 
AGG MT CCC GR ‘%A AAT ACA 'ITT GM CTG ATT CCC CTG GGG GAT GAG WG GAG AM AAT GM AU: ACC TtG CC4 GAG GGC AGG 255 
RNPGENTFELIPLGDEEEKNESrLPECR 73 . 
GCA AtC TAC TTA AAt AAA AGC CAC TCI CR GCA CCA CTT GCT CCC TX: ATC TCT GM CAT CCC TCh GGG TAT CtG ACC AGC CCC 339 
AIYLNKSHSPAPLAPFISEDASGYLTSP 101 . 
TGG CTG AGG CTC 7-X ATC CCC TCG GTT TAC ACC TTT GTG tTT GTC GTC AGC CTT CCT GIG AAC Al-C CTG GCC AtC GCA GTG ITT 
WLRLFIPSVYTFVFVVSLPLNILhIAVf 
__________________________-__________________________- J: _________________________________________v_____ 
GTC TTG MG AIG MG CTC AAA MG CCC GCI 'XC GTA TAC ATG CTG CAC CTG CCC AX: GCT CRC GTG CTG TTC GTC XC GTG CTT 
VLKHKVKKPAVVYWLWLAHADVLFVSVL 
_______ ______________________-______*___________________-._ rz __________ 
CCC CtG AM ATC AGC TAC TAC RT TCC GGC AGT GAT TGG CAG TIT GGC TCT GGG AtG TOT CGC TTC GCC ACT GCA GCG TTT TAT 591 
PLKISYYFSGSDWQFGSGWCRFATAAFY 195 
TGT MC ATG TAC GCC TCC ATC ATC CTC ATG ACT GTC ATA AGC ATT GAC CCC TX CTG GCA GTC RG TAC CCC AK CnG TCC GIG 675 
CNHYASIHLNTVISIDRFLAVVYPIQSL 213 
TCC l-s CGC AR RG ac AGA aT Mc TX ACT TGC CTG mc ATT Ta RG ATO GX ATC ATG GV, RG ctG ccr RT CTC mc 759 
SWRTLGRANFTCLVIWVHAIHGVVPLLL 241 
**““*****-****_--*******“*__****~____* N -****“--““**********“*****“*******_*** 
JAG GAG CAG ACC ACC GG TT CCA GGG CTC MC ATC ACC ACC TGC CAT GA1 RC CtC Mi GAG ACC CTG CiG CAG CCC TIT TAC 
KEQTTPVPGLNITTCHDVLNETLLQGFY 
* b 
TCC TIC TAC TTC Tee GCC TX xc GCT GK 'ITC TTT CTT GTG CCA TTG ATC ATT TCC ACG ATA TGC TAC ATG TCC ATC ATT ccc 
SYYFSAFSAVFFLVPLIISTICYHSII9, 
________________________________________________________ " _____________________________.________________ 
TGT CTC AGC TCC TCC TCA GTT GCC MC CGC AGC MC G,G KC CGG GCI TTG TTC CTG KC GCT GCt GTG TTC TGC OTC TTC ATC 
C.LSSSSVANRSKKSRALFLSAAVFCVFI 
***_-__ “***************___****~*****~~~*****”**” w 
GX TGC I-KT ~a ccc ACC ARC crc ctc m ATC ATG CAC TAC CTG CTC crc TCT GAC ~0c CCT GCC ACA GAG IUG ac mc TK: 
VCFGPTNVLLINHYLLLSDSPATEKAYF 
____________________________-___--___________-___________- __ 
GCT TAC CTC CA: TGC GTC Tm OTC AGC AGC GTG AGC TGC TGC ATC GAT CCC TTG ATT TAC TAC TAC CZC TCC TCC GAG TGC CAG 
AYLLCVCVSSVSCCIDPLIYYYASSECQ 
___________________________________ mr ___________________________________..____ 
Affi ACC CTC TAC CCC ATC TTG TGC TGC AAA GAA AGC TCC GAC CCC ARC AGT TAC AAC AGC ACC GGC CAG CTG ATC CCG AGT AAA 
RTLYGILCCHESSDPNSYNSTGQLHPSK 
ATG G&T ACC TGC TC'I AGT CAC CTG MT MC AGC ATA TAC AM MC CTA TTA GCT TAG GGFAGGATTGCTAGAnGGKACAThGAMJ,GGTTG 
HDTCSSHLNNSIYKKLLA' 
GMMFTGGAChGCCCGGGATC~G~~GM~ATA~TACTTCA~GCCATGACT~C~G~T~CTACTTC~A~A~GCTATCMGCAT~TTATCAG~G~ 
N\TGCW\ACCNjAW\GAGA~TCCAGTG~GCGGThCC 
T~TCMTGCTTTGnChCT~T~T~A~CCCTAG 
TATCThAn;ATAGffi~GffiT~ATAG~T~A~T~CAChaT~T~C~TATGTAT~T~~G~ATTT~TffiT~TGTTT~GTATA~~GTG~CAG 
TATTATCTGTATAffiGCMGAT~A~G~T~CATC~G~TTAC~CCGTTGG~~CTAT~T~TATGffiGTAC~T~~GC~T~hCATACT~TACAT 
GGnCeARGACTCACCAThCTCA~A~~T~~CC~A~G~C~ffiG~C~CT~~G~~TG~TACTT~CCA~T~G~TCCCMGAGA~ 
CCTCAiGCGGACCACCffiGCACTCCTrCClCChRGGCAGM 
TAGCCAC~GICCT~GCnCATC~~A~A~GMG~GTGT~ATAT~A~A~T~C~G~ffiCTGG~C~G~CAGA~CACCCAT~G~CTGG~CAC 
TCIGGTGGntACTffiGCCTGh~C~CCA~G~G~GA~~C~h~~G~T~A~CTA~ChGhTAG~GA~TGG~MTGTGA~TATACAC~C~ 
AThChCCATTCTAOITAGMGT~G~A~CACAChTCGCU 
423 
129 
507 
157 
843 
269 
927 
297 
1011 
325 
1095 
353 
1179 
391 
1263 
409 
1355 
427 
1466 
1577 
1688 
1799 
1910 
2021 
2132 
2243 
2354 
2465 
2576 
2687 
2798 
2856 
b. 
Fig. 2. (a) Nuclcotide and derived amino acid sequence of the hamster thrombin receptor cDNA pTG4403. A putative signal pcptidc (italics), 7 
putative transmcmbrane domains (TM I-VII) and four potential N-glycosylation sites (*) arc indicated under tbc amino acid scquoncc. The potcn- 
tial thrombin clcavagc site (R41) is dcnotcd by an arrow; details of the scqucncc surrounding the putative thrombin clcavagc site arc shown in Fig. 
3. The primer pair uacd for PCR (see Section 2) amplifies the region bctwcen nuclcotidc position 460 and 646 (including the primer scqucnccs). 
(b) Hydophilicity of the translated 427 amino acid sequcncc from pTG4403 was dctcrmincd using the Kytc-Doolitrlc rcalc [35]. 
analogy with the topographic model for other members 
of this receptor family, the first hydrophobic domain is 
likely to represent a signal pcptidc, with a probable 
signal peptidasc cleavage site after Serine-22 or 
Serine-21 [23]. Four potential Mglycosylation sites arc 
126 
present, including two in the N-terminal cxtraccllular 
domain, and two in the second extracellular loop which 
may bc involved in receptor localization [24]. 
Since the proteolytic activity of thrombin is rcquircd 
for its biological cffcct on CCL39 cells, the cxtrncellular 
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domains were searched for consensus thrornbin 
cleavage sites and sequence similarly with other proteins 
that interact specifically with the enzyme. Results of 
these analysis are presented in Fig. 3. A thrombin 
cleavage site typicalIy contains the sequence 
P4-P3-P2-(Arg/Lys)-PI ‘-P2’ where P2, P3 and P4 are 
hydrophobic residues and P! ’ and P2’ are non-acidic, 
particularly when P2 is a Proline [25]. At Arginine-41 in 
the translated sequence of pTG4403, a characteristic 
thrombin cleavage site is present. A putative thrombin 
cleavage site at this position was also found in the 
human thrombin receptor which was reported during 
the course of this work [26]. A negatively charged 
cluster of residues is located approximately 20 amino 
acids C-terminal to the cleavage site. 
A negatively charged domain or acidic stretch is pre- 
sent in several proteins which bind thrombin, and 
found near the cleavage site in proteins cleaved by 
thrombin. This domain presumably interacts with the 
anion-binding exosite of thrombin and contributes to 
the enzyme’s pecificity. In fibrinogen Aa a negatively 
charged domain is located about 20 amino acids C- 
terminal to the thrombin cleavage site, similar to the 
thrombin receptor (Fig. 3). For Factor VIII; an acidic 
domain about 20 residues C-terminal to the thrombin 
cleavage site is aligned with the thrombin receptor in 
Fig. 3, but other acidic domains are present in the 
molecule approximately 20 residues N-terminal to 
thrombin cleavage sites (positions 3721393 and 
1689/1690) [29]. Heparin cofactor II and hirudin, 
which both complex thrombin, also possess anegatively 
charged cluster of amino acids. In fact it has been 
shown that the acidic C-terminus of hirudin interacts 
with the anion-binding exosite of thrombin [28], and 
that synthetic peptides derived from the C-terminal 20 
residues of hirudin possess anticoagulant activity [29]. 
Interesting sequence similarity exists between residues 
56-60 in hirudin (FEEIP) and residues 53-59 (FELIP) 
in the hamster thrombin receptor, residues that are ab- 
sent in the human thrombin receptor sequence (Fig. 3). 
Overall amino acid sequence identity between the 
hamster and the recently reported human thrombin 
receptor is 99rr/,. This is low compared to 89% overall 
sequence identity between the hamster [30] and human 
[31 J) 02 adrenergic receptor, and >90% between the 
rat and human forms of the muscarinic ml, dopamine 
D2 receptors and the n1a.s oncogene. The cytoplasmic 
loops, which presumably play a role in G-protein cou- 
pling, are more highly conserved indicating that the 
hamster and human thrombin receptors utilize the same 
intracellular signalling systems. Sequence identities in 
the first, second and third intracellular loops are 100,95 
and 93 respectively, whereas they range from 68 to 91 Vo 
in the transmembrane domains. The lowest homology 
between human and hamster thrombin receptor is 
observed in the N-terminal extracellular domain which 
is 55% (excluding the signal peptide). Altogether these 
results suggest that the hamster sequence may represent 
a different receptor isoform coupled to PLC, however 
further studies including genomic Southern analyses are 
required to clarify this point. 
Concerning amino acid identity of the thrombin 
receptor with the transmembrane domains of the 9 
receptors aligned for primer design (see Section 2), 
values ranged from: 19-30% in TMI, 23-41010 in TMII, 
23-36% in TMIII, 1 l-32% in TMIV, 23-37070 in TMV, 
22-30% in TMVI and 14-32% in TMVII. Apart from 
its human homolog, the hamster thrombin receptor 
displayed highest overall identity (27%) to the human 
cytomegalovirus sequence HCMVU28 1321, with 55, 41 
and 32% in TMII, III, and VII, threedomains that have 
been implicated in ligand binding in the case of 
adrenergic receptors [24]. It is interesting to note that 
the HCMVVLT28 sequence has a negatively charged 
cluster of residues in the N-terminal domain (DYDED), 
but a putative thrombin cleavage site in the short N- 
terminal domain is absent. 
At positions 179 and 256 in the first and second ex- 
tracellular domains, two Cysteins are present hat are 
highly conserved in G-protein-coupled receptors and 
may be involved in an essential disulfide bridge impor- 
tant for maintaining receptor structure [33]. Two 
Lysines in a basic surrounding are present in the third 
intracellular loop (position 309 and 310); a similar 
motif is present at this position in many receptors of 
this family [32] and may be involved in G-protein cou- 
pling. It is noteworthy that this third intracellular loop, 
which varies in length among the different receptors of 
this gene family, is only 14 residues long in the throm- 
bin receptor. Potential sites for modification of the 
65 
Fig. 3. hligwiicn~ of tllc cstraccll~llar N4crmlnd domitl or lhc hmslcr rhronibiii rcccptor with ollicr Uiroiilbin lmmins 11141 inwast wilti. Pro- 
reins nligncd ineludc: the hmrwr lhranbia rsscplot, thc IWIIRH thrnrnhi~r trmptm [26!, huwar, Art I Zrir;nEcn [?A), humon fxror VIII 1271, 
hirudin varbnt I [37J. nnd Iiclwitl darcor II [M). A throtrjhhl slcawgc~i~c ml n cmnlon rwgaGvc charpc cluskzr wc shown dmc the acqucncca. 
t-loiiinlngi~~ lo Ihe hnmslcr throtnhiu rcccplnr me hoxd; Asp (LA alld Glu (E) are boxed lopclhcr since they ilrc bolli IlCgilliVCly chnrpcd, as well 
3s Lyf (K) aild Arg (H) which im bollt poni\ivcly zhnrgcd. 
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thrombin receptor activity and/or desensitization by 
phosphorylation are present including 3 Threonine and 
10 Serine residues in the cytoplasmic C-terminal do- 
main, six of which are in pairs next Co a charged amino 
acid, and 6 Serines in the third intracellular loop. A 
potential tyrosine kinase phosphorylation site [34] is 
located at. Tyrosine 399. 
[8] Brass, L.F.. Manning, D.R.. Williams, A.G., Woolkalis. M.J. 
and Poncz, M. (1991) 1. Biol. Chem. 266, 958-965. 
PI Van Obberghen-Schilling. E., Chambard, J.C., Paris, S., 
L’Allemain. G. and Pouyssegur. J. (1985) EMBO J. 4, 
2927-2932. 
In conclusion, the cDNA we have isolated encodes a 
functional thrombin receptor with structural features of 
a G-protein-coupled receptor. A thrombin consensus 
cleavage site and negative charge cluster are present in 
the N-terminal extracellular domain of the receptor, 
consistent with recent evidence that thrombin receptor 
activation involves a novel proteolytic mechanism by 
which thrombin cleaves its receptor to create a new 
amino terminal that functions as a ligand to activate the 
receptor [26]. In this study by Vu et al. a synthetic pep- 
tide of 14 residues corresponding to the new receptor N- 
terminal was shown to activate the cloned thrombin 
receptor in oocytes an induce platelet activation. Subse- 
quently, we ha<e found that a peptide corresponding to 
only 7 residues proximal to the thrombin cleavage site in 
the hamster sequence (Serine-42-Proline-48) both ac- 
tivates PEC and inhibits adenylate cyclase in CCL39 
cells (manuscript in preparation). These results suggest 
that either the cloned receptor is coupled to at least two 
distinct G proteins, or that more than one receptor sub- 
type is present in these cells and can be activated by the 
peptide. We are currently investigating these possibi- 
lities. Interestingly, the receptor peptide does not 
stimulate DNA synthesis in CCL39 cells but rather it 
potentiates the action of the tyrosine kinase-activating 
fibroblast growth factor (in preparation). Therefore we 
believe that mitogenic stimulation of cells by thrombin 
requires yet an additional pathway involving a tyrosine 
kinase. 
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